Alpha-melanocyte stimulating hormone (
alpha-MSH) is known to have pleiotrophic functions including pigmentary, anti-inflammatory,
antipyretic and immunoregulatory roles in the mammalian body. It is also reported to influence
melanoma invasion with levels of alpha-, beta- and
gamma-MSH correlated clinically with
malignant melanoma development, but other studies suggest
alpha-MSH acts to retard invasion. In the present study, we investigated the action of
alpha-MSH on three human
melanoma cell lines (HBL, A375-SM and C8161) differing in metastatic potential. alpha-melanocyte-simulating
hormone reduced invasion through
fibronectin and also through a human reconstructed skin composite model for the HBL line, and inhibited proinflammatory
cytokine-stimulated activation of the
NF-kappaB transcription factor. However, A375-SM and C8161 cells did not respond to
alpha-MSH. Immunofluorescent microscopy and Western blotting identified
melanocortin-1 receptor (MC-1R) expression for all three lines and MC-2R on HBL and A375-SM lines. Receptor binding identified a similar affinity for
alpha-MSH for all three lines with the highest number of binding sites on HBL cells. Only the HBL
melanoma line demonstrated a detectable cyclic
adenosine monophosphate (cAMP) response to
alpha-MSH, although all three lines responded to acute
alpha-MSH addition (+(-)-N(6)-(2-phenylisopropyl)-
adenosine (PIA)) with an elevation in intracellular
calcium. The nonresponsive lines displayed MC-1R polymorphisms (C8161, Arg (wt) 151/Cys 151; A375-SM, homozygous Cys 151), whereas the HBL line was wild type. Stable transfection of the C8161 line with wild-type MC-1R produced cells whose invasion was significantly inhibited by
alpha-MSH. From this data, we conclude that
alpha-MSH can reduce
melanoma cell invasion and protect cells against proinflammatory
cytokine attack in cells with the wild-type receptor (HBL).